Montreal EpiTerapia is dedicated to harnessing the power of novel genetic and epigenetic science and providing new diagnostic assays based on next generation sequencing and DNA methylation for detecting and predicting disease and disease risk in emerging markets with a specific focus on Euro-Asia. Montreal EpiTerapia is an exclusive distributor of a novel method to treat human addiction for DHEA horizon. The company is planning to expand it's epigenetic and genetic diagnostics operation by setting up “next generation” diagnostic labs in several countries in EuroAsia and by licensing new diagnostic assays as they become available.

Harnessing the potential of genetics and epigenetics for new therapeutics and diagnostics